Aibili Logo Association for Innovation and Biomedical Research on Light

Ongoing Projects

Coimbra Ophthalmology Reading Centre

Framework to Develop and Validate Automated Image Analysis Systems for Early Diagnosis and Treatment of Eyes at Risk in Blinding Age-Related Diseases. (FILTER) [more info]

Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive Imaging methods, in a longitudinal and prospective clinical Study with 2 years of duration. (CORDIS, Protocol CEC010/2018) [more info]

A Phase 2, randomised, single-masked, active-controlled, multicentre study to evaluate the efficacy and safety of intravitreal THR-317 when administered alone or in combination with Lucentis®, in diabetic macular oedema (DME) patients with a poor or no response to anti vascular endothelial growth factor (anti-VEGF) treatment. (Protocol THR-317-002) [more info]

A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects with Retinitis Pigmentosa. (Protocol GS030_CLIN_001) [more info]

RetmarkerAMD Software Validation [more info]

Progression of Diabetic Retinopathy. Identification of Signs and Surrogate outcomes. (PROGRESS, Protocol CEC/007/16) [more info]

A Phase 2, single-masked, multicentre study to evaluate the safety and efficacy of 2 dose levels of THR-317 for the treatment of diabetic macular oedema (DME). (Protocol THR-317-001) [more info]

OCT-A (Optical Coherence Tomography Angiography): Evaluation and Comparison with FA. [more info]

AMD Incidance Central Portugal - Coimbra Eye Study: The five-year incidence of Age-Related Macular Degeneration. A clinical study with color fundus photography, optical coherence tomography and blood sample collection in Mira. (AMD Incidence_CPT, Protocol 4C-2016-09) [more info]

An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of three different treatment regimens of 2 mg Eylea administered by intravitreal injections to subjects with diabetic macular edema (DME). (VIOLET, Protocol BAY 86-5321 / 17613) [more info]

1 2

Projects by department:

  -   Cloud   -  Copyright © AIBILI   -   Contact Us   -   Site Map   -   Privacy Policy  -  Cookies Policy  -  Webdesign Glitz Design   -   Programming Bizview